These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 16019174)

  • 41. Average optimal DPOAE primary tone levels in normal-hearing adults.
    Marcrum SC; Kummer P; Kreitmayer C; Steffens T
    Int J Audiol; 2016; 55(6):325-32. PubMed ID: 27010374
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optimum primary tone level setting for measuring high amplitude DPOAEs in guinea pigs.
    Michaelis CE; Gehr DD; Deingruber K; Arnold W; Lamm K
    Hear Res; 2004 Mar; 189(1-2):58-62. PubMed ID: 14987752
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Hearing evaluation in chronic renal failure children].
    Hajduk A; Lisowska G; Namysłowski G; Szprynger K; Szczepańska M; Widziszowska A
    Otolaryngol Pol; 2006; 60(1):61-6. PubMed ID: 16821544
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Distortion-product otoacoustic emission measured with continuously varying stimulus level.
    Neely ST; Johnson TA; Gorga MP
    J Acoust Soc Am; 2005 Mar; 117(3 Pt 1):1248-59. PubMed ID: 15807014
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Contralateral suppression of latency during distortion product otoacoustic emissions detection in guinea pigs].
    Kong W; Yang Y; Zhang W
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Aug; 36(4):271-4. PubMed ID: 12761994
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of furosemide on distortion product otoacoustic emissions and on neuronal responses in the anteroventral cochlear nucleus.
    Rübsamen R; Mills DM; Rubel EW
    J Neurophysiol; 1995 Oct; 74(4):1628-38. PubMed ID: 8989399
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Repeatability of distortion product otoacoustic emissions in normally hearing humans.
    Roede J; Harris FP; Probst R; Xu L
    Audiology; 1993; 32(5):273-81. PubMed ID: 8216026
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of spontaneous otoacoustic emissions on distortion product otoacoustic emission.
    Kuroda T; Fukuda S; Chida E; Kashiwamura M; Matsumura M; Ohwatari R; Inuyama Y
    Auris Nasus Larynx; 2001 May; 28 Suppl():S33-8. PubMed ID: 11683340
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Negative Middle Ear Pressure and Composite and Component Distortion Product Otoacoustic Emissions.
    Thompson S; Henin S; Long GR
    Ear Hear; 2015; 36(6):695-704. PubMed ID: 26049553
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exploring Optimal Stimulus Frequency Ratio for Measurement of the Quadratic f2-f1 Distortion Product Otoacoustic Emission in Humans.
    Baiduc RR; Dhar S
    J Speech Lang Hear Res; 2018 Jul; 61(7):1794-1806. PubMed ID: 29946695
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Age-related declines in distortion product otoacoustic emissions utilizing pure tone contralateral stimulation in CBA/CaJ mice.
    Varghese GI; Zhu X; Frisina RD
    Hear Res; 2005 Nov; 209(1-2):60-7. PubMed ID: 16061336
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Distortion product otoacoustic emissions for the assessment of auditory sensitivity].
    Chida E
    Nihon Jibiinkoka Gakkai Kaiho; 1998 Nov; 101(11):1335-47. PubMed ID: 9867000
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Contralateral suppression of DPOAE measured in real time.
    James AL; Mount RJ; Harrison RV
    Clin Otolaryngol Allied Sci; 2002 Apr; 27(2):106-12. PubMed ID: 11994116
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Distortion product otoacoustic emissions in normally hearing young humans].
    Dan H; Ni D; Li F
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Jun; 20(3):207-11. PubMed ID: 11367707
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationships among standard and wideband measures of middle ear function and distortion product otoacoustic emissions.
    Schairer KS; Morrison B; Szewczyk E; Fowler CG
    J Am Acad Audiol; 2011 May; 22(5):253-64. PubMed ID: 21756841
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adaptation of distortion product otoacoustic emission in humans.
    Kim DO; Dorn PA; Neely ST; Gorga MP
    J Assoc Res Otolaryngol; 2001 Mar; 2(1):31-40. PubMed ID: 11545148
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The influence of gender on otoacoustic emissions in normally hearing subjects].
    Namysłowski G; Lisowska G; Misiołek M; Scierski W; Orecka B; Czecior E
    Otolaryngol Pol; 2007; 61(5):792-5. PubMed ID: 18552021
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Otoacoustic emissions measurements in children during the chemotherapy because of the acute lymphoblastic leukemia].
    Lisowska G; Namysłowski G; Hajduk A; Polok A; Tomaszewska R; Misiołek M
    Otolaryngol Pol; 2006; 60(3):415-20. PubMed ID: 16989457
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sources of DPOAEs revealed by suppression experiments, inverse fast Fourier transforms, and SFOAEs in impaired ears.
    Konrad-Martin D; Neely ST; Keefe DH; Dorn PA; Cyr E; Gorga MP
    J Acoust Soc Am; 2002 Apr; 111(4):1800-9. PubMed ID: 12002864
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Distortion product otoacoustic emission suppression tuning curves in normal-hearing and hearing-impaired human ears.
    Gorga MP; Neely ST; Dierking DM; Dorn PA; Hoover BM; Fitzpatrick DF
    J Acoust Soc Am; 2003 Jul; 114(1):263-78. PubMed ID: 12880040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.